Lynx.MD’s Post

🔬Life Sciences and MedTech companies face a critical challenge: understanding the real-world impact of therapeutics on patients after market entry. 💡 @Lynx.MD bridges the gap between healthcare partners and Life Sciences/MedTech innovators to bring real-world longitudinal data that delivers the insights you need now to understand patient outcomes. 📊🤝 Ready to explore the future of healthcare? Swipe through our infographic to preview the data assets we bring to innovation. 🚀 👉 Contact our team on LinkedIn today, Collin Labar, Robert Eisdorfer, MD, Jody Bare. https://lynx.md/ hashtag #RealWorldData #LifeSciences #MedTech #HealthcareInnovation #PatientOutcomes

The latest trends in the diagnostic industry are ushering in an era of innovation. As the industry learns to consistently navigate coverage and reimbursement, the push for advanced diagnostics is enabling healthcare providers to tailor treatments to specific variants. This advancement is not only improving patient outcomes but also enhancing the precision of medicine. Join industry experts Elliott Greenspan, CIO and Co-Founder, @Igentify, Lishan Aklog, MD, Chairman and CEO, Lucid Diagnostics, Rollie Carlson, Ph.D. Carlson, CEO, Immunexpress Inc. Inc and Mike Ward, Head of Thought Leadership for Life Sciences & Healthcare, Clarivate, as they discuss these innovations. https://lnkd.in/ea76Ckak #MedTech #Diagnostics

With 20+ years' experience across #biopharma, Randy Quist has seen Patient Access & Support evolve to enable greater visibility and control over the end-to-end experience. Follow the link below to learn how Randy and four other industry thought leaders are “Redefining Market Access” to ensure patients start and stay on therapy: https://bit.ly/3N6SpOF "Every single patient that is appropriate for therapy that doesn’t start or discontinues because of an administrative challenge or something that could be avoided is a loss," says Randy. #patientexperience #innovators #patientcentric #patientfirst

👀 New white paper just launched! Check out this fresh resource exploring emerging direct-to-consumer models in #pharma and how #lifesciences leaders are harnessing the power of virtual care to engage patients in innovative ways. https://lnkd.in/gXEqbChr Key Topics:  🔸 Life sciences market dynamics in 2024  🔸Emerging DTC models for pharma 🔸An overview of current in-market virtual care programs 🔸A benefit analysis of virtual care for life sciences including key challenges and considerations 👉 Download this free white paper today! #lifesciences #pharma #whitepaper #consumerhealth #virtualcare #telehealth

A new study demonstrated that Extended-release buprenorphine (XR-Bup) was associated with a reduction in ED use six months after initiation, indicating a potential increase in patient adherence and a reduction in healthcare system costs overall (https://lnkd.in/e5XpSMnZ). Incremental or sustaining drug innovations like XR-Bup can disrupt the market and create enormous value for stakeholders. Ideas don't always have to be disruptive to create impact. Whether you have an idea for an incremental or a disruptive innovation, our program can help you identify how to move it into the market. Apply today - https://lnkd.in/e9FiW56p

𝐃𝐫𝐮𝐠 𝐃𝐞𝐯𝐞𝐥𝐨𝐩𝐦𝐞𝐧𝐭 2.0: 𝐈𝐭 𝐒𝐭𝐚𝐫𝐭𝐬 𝐰𝐢𝐭𝐡 𝐭𝐡𝐞 𝐏𝐚𝐭𝐢𝐞𝐧𝐭 What if the key to developing better treatments wasn't just hidden in labs but in the voices of patients themselves? That's the powerful message from a recent research paper that is reshaping how we think about drug development. It highlights the importance of incorporating patient perspectives early on, from understanding their needs and experiences to collaborating with them throughout the research process. This shift toward patient-centricity can lead to: - More effective treatments - Improved patient outcomes - A more human-centered healthcare system In my latest Substack article, you can learn more about this approach and explore the four key pillars of patient-centricity based on the paper. 🆕 https://lnkd.in/e4gdhtVc 🔬 doi: 10.1177/2168479017716492

One of my favorite conferences in healthcare is happening today in NYC: The Financial Times US Pharma and Biotech Summit. Influence and impact in the healthcare industry is constantly shifting due to advancing technology, customer expectations, and policy reforms. I will be participating in an important panel discussion "Connecting with Patients and Redefining the Relationship" with: Eden Wells, Debra Jennings, Zachariah Reitano, and Oliver Barnes. Not only will I get to share my insights on how pharma companies, insurers, and other stakeholders are adapting to the changes and evolving their relationships with their patients, but I get to learn different aspects of this topic from my fellow panelists - this is actually my favorite part! #FTPharma #PatientCentricity

How do you know if a particular medicine is working? Traditionally, it takes guesswork on the physician’s part and time to find a drug that works for any given patient. But what if we could leverage digital biomarkers to measure the efficacy of a medication very quickly and course correct as needed? Rich Carter serves as Chief Digital Officer at Eli Lilly and Company, where he oversees the teams focused on innovation, user-centered design and digital health. On this episode of The Beat, Rich discuss the future of drug development and clinical trials, exploring what digital transformation means in the context of life sciences, explaining how technology can improve drug discovery and accelerate the timeline from discovery to market. 🎧 Listen now: https://lnkd.in/e7NpEQUx #TheBeat #HealthcareInnovation #DigitalHealth

Innovations like virtual health communities, digital therapeutics, and on-demand lab tests are transforming the healthcare landscape. Here are five trends to know: https://okt.to/wXNc1G #DKSH #DKSHInsights #digitalhealth #virtualhealth #healthcaresolutions

New Healthcare Trend Report 💡 The Antibody-Drug Conjugate (ADC) market is projected to reach $44 billion by 2029. Increased M&A activity, clinical trial expansion, and a focus on precision medicine are driving this exciting sector. Watch our latest video from Tennyson Young to learn why this sector is attracting major investment. Check out the full report here: https://bit.ly/40fCogO #ExpertNetwork #HealthcareInvestment #PrivateEquity #PrivateEquityInvestment